Humacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma Post author: Post published:March 1, 2026 Post category: Continue ReadingHumacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma
A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease Post author: Post published:March 1, 2026 Post category: Continue ReadingA Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease
A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma Post author: Post published:March 1, 2026 Post category: Continue ReadingA Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma
AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC) Post author: Post published:March 1, 2026 Post category: Continue ReadingAB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)
Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma Post author: Post published:March 1, 2026 Post category: Continue ReadingSafety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR) Post author: Post published:March 1, 2026 Post category: Continue ReadingDose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)
Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax Post author: Post published:March 1, 2026 Post category: Continue ReadingCirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax
CNS10-NPC-GDNF Delivered to the Motor Cortex for ALS Post author: Post published:March 1, 2026 Post category: Continue ReadingCNS10-NPC-GDNF Delivered to the Motor Cortex for ALS
Continued Evaluation of Patients With Parkinson’s Disease Who Previously Received BRT-DA01 Post author: Post published:March 1, 2026 Post category: Continue ReadingContinued Evaluation of Patients With Parkinson’s Disease Who Previously Received BRT-DA01
A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL) Post author: Post published:March 1, 2026 Post category: Continue ReadingA Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)
